A 66-year-old man with prostate cancer had his tumor removed without the surgeon ever stepping into his operating room. Dr.

The FDA has expanded its approval of talazoparib in combination with enzalutamide to include men with metastatic androgen ...

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...

A PSA level of 28.9 is significantly elevated, but does it confirm prostate cancer? Doctors explain what it could mean and ...

Speaking at the grand opening of the medical facility on Hope Road in St Andrew last Thursday, Morrison-Blidgen told the ...

Briganti and colleagues concluded that, together with the main PROTEUS study, the substudy supports 1-year perioperative apalutamide plus ADT as a treatment option for patients with high-risk ...

Adding abiraterone to standard treatment provides a lasting survival benefit for men whose prostate cancer has already spread ...

P-Protect Patch, its PProtect patch-based format, product information, ingredient transparency, safety considerations, and general prostate health awareness.

King Charles announced he was suffering from a type of cancer in February 2024.

P-Protect Patch is a men's wellness product that brings prostate health awareness, ingredient transparency, responsible use, and informed healthcare decisions into the conversation.

It's often not the man who notices something first. His partner may mention noticing he has been up three or four times a ...

Mr Sanjith Gnanappiragasam, Consultant Urological Surgeon at King’s, said: “Delivering this type of treatment within 15 ...